ESR1 Inhibitors and Breast Cancer Therapy Advances
ESR1 mutations in breast cancer pose significant challenges, particularly in treatment-resistant cases of hormone receptor-positive metastatic disease. Understanding these mutations enhances treatment strategies and highlights the importance of early detection. Exploring innovations such as ESR1 inhibitors and advancements in clinical trials offer hope for improved management and patient outcomes in the evolving landscape of breast […]
3 minute read